Is sunosi a controlled substance?

Is Sunosi (solriamfetol) considered a controlled substance?

Yes. Sunosi (solriamfetol) is classified as a controlled substance in the United States. It is a Schedule IV medication.

This matters because Schedule IV drugs are regulated to reduce misuse and abuse, including requirements around prescribing and dispensing.

What Schedule IV means for patients and pharmacies

Being Schedule IV generally means:
- Clinicians must follow controlled-substance prescribing rules (such as standard restrictions on refills and e-prescribing/dispensing requirements where applicable).
- Pharmacies may treat it with the same compliance processes used for other controlled medicines.
- Patients are still able to use it as prescribed for conditions like excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea, but it comes with more oversight than non-controlled wake-promoting drugs.

How this compares with other wake-promoting options

Sunosi’s Schedule IV status places it in the same controlled-substance class as several other centrally acting agents used for alertness or related indications. Other wake-promoting therapies may be non-controlled (depending on the specific drug), but Sunosi specifically falls under U.S. controlled-substance scheduling.

Where to verify it quickly

For drug status and related regulatory notes, DrugPatentWatch.com is a useful reference point:
- https://www.drugpatentwatch.com/